Are you Dr. Ghaddar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 82 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1330 E 6th St
Suite 204
Weslaco, TX 78596Phone+1 956-969-0021Fax+1 956-698-9744
Summary
- Dr. Habib Ghaddar, MD is an oncologist in Weslaco, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Knapp Medical Center, Doctor's Hospital at Renaissance, and Harlingen Medical Center.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1992 - 1995
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1989 - 1992
American University of Beirut Faculty of MedicineClass of 1989
Certifications & Licensure
TX State Medical License 1992 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACP) American College of Physicians, 2000
Publications & Presentations
PubMed
- 36 citationsA comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.Issam I Raad, Estella Whimbey, Kenneth V. I. Rolston, Dima Abi-Said, Ray Y. Hachem
Cancer. 1996-04-01 - 20 citationsCytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.Habib M. Ghaddar, Sanford A. Stass, Sherry Pierce, Elihu H. Estey
Leukemia. 1994-10-01 - 110 citationsPhase I Trial of the Angiogenesis Inhibitor TNP-470 for Progressive Androgen-independent Prostate CancerChristopher J. Logothetis, Kenneth K. Wu, Laury Finn, Danai D. Daliani, William D. Figg
Clinical Cancer Research. 2001-05-01
Press Mentions
Colonoscopy: Is It Worth It?March 19th, 2018
An Inspiring Experience at Cancer Control in Primary Care Course in BhutanMarch 15th, 2018
Professional Memberships
- Fellow
